Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ER
Acta Pharmaceutica Sinica B
; (6): 442-455, 2021.
Article
de En
| WPRIM
| ID: wpr-881146
Bibliothèque responsable:
WPRO
ABSTRACT
Although different types of drugs are available for postmenopausal osteoporosis, the limitations of the current therapies including drug resistances and adverse effects require identification of novel anti-osteoporosis agents. Here, we defined that norlichexanthone (NOR), a natural product, is a ligand of estrogen receptor-alpha (ER
Texte intégral:
1
Indice:
WPRIM
langue:
En
Texte intégral:
Acta Pharmaceutica Sinica B
Année:
2021
Type:
Article